3 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital

Page 3 of 3

1. Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Stake Value of Consonance Capital Management: $58,177,000

Percentage of Consonance Capital Management’s 13F Portfolio: 31.84%

Number of Hedge Fund Holders: 31

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is a medical device company that designs, develops, and markets various products for diabetic individuals in the United States. On January 19, 2022, Wells Fargo analyst Lawrence Biegelsen upgraded Tandem Diabetes Care, Inc. (NASDAQ:TNDM) to Overweight from Equal Weight and gave the stock a $160 price target.

By the end of the third quarter of 2021, 31 hedge funds held stakes in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) worth $287.12 million. Of these stakes, Consonance Capital had invested a hefty $58.17 million in the company which is its top holding and accounts for 31.84% of its investment portfolio.

You can also take a look at 20 Biggest Healthcare Companies By Revenue and 10 Best Healthcare Dividend Stocks.

Page 3 of 3